⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29573356 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL597675 | 0.97 | L3MBTL1 (0.50) | — | |
| Hydrochloric Acid SCHEMBL30267828 | 0.97 | L3MBTL1 (0.50) | — | |
| Bromide SCHEMBL20984641 | 0.97 | L3MBTL1 (0.50) | — | |
| Hydrochloric Acid SCHEMBL6780328 | 0.95 | L3MBTL1 (0.48) | — | |
| Hydrochloric Acid SCHEMBL838681 | 0.95 | L3MBTL1 (0.48) | — | |
| Bicarbonate SCHEMBL31492033 | 0.89 | KMT2A (0.53) | — | |
| Oxalic Acid SCHEMBL20984924 | 0.87 | KMT2A (0.52) | — | |
| Sulfuric Acid SCHEMBL20984747 | 0.87 | CA1 (0.53) | — | |
| Phosphoric Acid SCHEMBL20984859 | 0.87 | L3MBTL1 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 397 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC | 2025-06-26 | — | — | US | claimed |
| EP-4568953-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2025-06-18 | — | — | EP | claimed |
| CN-116903496-B | Preparation method and application of phenylhydrazinoformate menthyl ester compounds | 南京林业大学 | 2025-05-23 | — | — | CN | claimed |
| CN-119894883-A | Methods and processes for preparing MCT4 inhibitors | 维托尔股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-119080711-A | Preparation method and application of myrtenyl-1, 3, 4-oxadiazole formylhydrazine compound | 南京林业大学 | 2024-12-06 | — | — | CN | claimed |
| CN-118930487-A | 1,3, 5-Trisubstituted pyrazole compound and preparation method thereof | 赣南师范大学 | 2024-11-12 | — | — | CN | claimed |
| CN-118084717-A | Phenylhydrazine-based multifunctional molecular additive for perovskite solar cell, and preparation method and application thereof | 正泰新能科技股份有限公司 | 2024-05-28 | — | — | CN | claimed |
| WO-2024031445-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2024-02-15 | — | — | WO | claimed |
| CN-116903496-A | Preparation method and application of phenylhydrazinoformate menthyl ester compounds | 南京林业大学 | 2023-10-20 | — | — | CN | claimed |
| CN-113121382-B | Metal compound material and preparation method thereof, quantum dot light emitting diode and light emitting device | TCL科技集团股份有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-114736226-A | Method for simply preparing boron-nitrogen-pyridine compound | 南开大学 | 2022-07-12 | — | — | CN | claimed |
| CN-114685549-A | Preparation method of novel four-coordination bisboranofluorene fluorescent compound | 南开大学 | 2022-07-01 | — | — | CN | claimed |
| CN-113121382-A | Metal compound material and preparation method thereof, quantum dot light-emitting diode and light-emitting device | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-112010798-A | Method for synthesizing N-arylcarbazole compound by catalyzing reaction of carbazole and arylhydrazine with transition metal | 新乡市润宇新材料科技有限公司 | 2020-12-01 | — | — | CN | claimed |
| CN-110003160-A | A kind of Osthole hydrazone class/acylhydrazone class/sulphur acylhydrazone and preparation method thereof and application | 贵州中医药大学 | 2019-07-12 | — | — | CN | claimed |
| CN-108264488-A | A kind of preparation method for replacing phthalazone class compound | 天津瑞岭化工有限公司 | 2018-07-10 | — | — | CN | claimed |
| CN-102838507-A | Preparation technology of 4-bromophenylhydrazine | GUO MEI | 2012-12-26 | — | — | CN | claimed |
| CN-102382010-A | Preparation process for 4- bromo phenyl hydrazine | XUECHONG YUAN | 2012-03-21 | — | — | CN | claimed |
| EP-0918052-B1 | Improved polymeric mdi color | BAYER AG (US) | 2003-05-28 | — | — | EP | claimed |
| US-20260098040-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA CELLULAR THERAPIES INC (US) | 2026-04-09 | — | — | US | disclosed |
| EP-3609891-B1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA CELLULAR THERAPIES INC (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-3898581-B1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA CELLULAR THERAPIES INC (US) | 2025-08-27 | — | — | EP | disclosed |
| US-12358916-B2 | Substituted heterocycle fused gamma-carbolines synthesis | INTRA-CELLULAR THERAPIES, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250206723-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC | 2025-06-26 | — | — | US | disclosed |
| EP-4568953-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| CN-116903496-B | Preparation method and application of phenylhydrazinoformate menthyl ester compounds | 南京林业大学 | 2025-05-23 | — | — | CN | disclosed |
| US-12297200-B2 | Substituted heterocycle fused gamma-carbolines synthesis | INTRA-CELLULAR THERAPIES, INC. (US) | 2025-05-13 | — | — | US | disclosed |
| CN-119894883-A | Methods and processes for preparing MCT4 inhibitors | 维托尔股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| CN-119390700-A | Pyrazolopyrimidinone derivative containing aniline unit, and preparation method and application thereof | 江苏海洋大学 | 2025-02-07 | — | — | CN | disclosed |
| CN-119178831-A | Optimized 3-nitrophenylhydrazine derivatization method and application | 中国药科大学 | 2024-12-24 | — | — | CN | disclosed |
| CN-119080711-A | Preparation method and application of myrtenyl-1, 3, 4-oxadiazole formylhydrazine compound | 南京林业大学 | 2024-12-06 | — | — | CN | disclosed |
| CN-118930487-A | 1,3, 5-Trisubstituted pyrazole compound and preparation method thereof | 赣南师范大学 | 2024-11-12 | — | — | CN | disclosed |
| EP-4442318-A2 | HETEROCYCLIC INHIBITORS OF MCT4 | Vettore, LLC (US) | 2024-10-09 | — | — | EP | disclosed |
| US-20240327409-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2024-10-03 | — | — | US | disclosed |
| CN-118406028-A | Hydrazide compound containing alpha-methylene-gamma-butyrolactone structure, preparation method and application thereof | 西北农林科技大学 | 2024-07-30 | — | — | CN | disclosed |
| EP-3551625-B1 | HETEROCYCLIC INHIBITORS OF MCT4 | VETTORE LLC (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-118084717-A | Phenylhydrazine-based multifunctional molecular additive for perovskite solar cell, and preparation method and application thereof | 正泰新能科技股份有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-114685549-B | Preparation of tetra-coordination diboron nitrogen fluorene fluorescent compound | 南开大学 | 2024-05-24 | — | — | CN | disclosed |
| CN-113227045-B | Synthesis of substituted heterocycle fused gamma-carbolines | 细胞内治疗公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-113195450-B | Synthesis of substituted heterocycle fused gamma-carbolines | 细胞内治疗公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2024031445-A1 | METHODS AND PROCESSES FOR THE PREPARATION OF MCT4 INHIBITORS | Vettore, LLC (US) | 2024-02-15 | — | — | WO | disclosed |
| CN-116903496-A | Preparation method and application of phenylhydrazinoformate menthyl ester compounds | 南京林业大学 | 2023-10-20 | — | — | CN | disclosed |
| WO-2022183008-A9 | AMINO-BENZIMIDAZOLE CATALYSTS FOR THE PREPARATION OF POLYOLEFINS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-10-12 | — | — | WO | disclosed |
| WO-2023192506-A1 | MALT1 MODULATORS AND USES THEREOF | RARIFIED BIOSCIENCES, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| CN-116655536-A | Class N 1 -aryl-3-fluoroalkyl-5-fluoropyrazole compound, and preparation method and application thereof | 天津大学 | 2023-08-29 | — | — | CN | disclosed |
| CN-113121382-B | Metal compound material and preparation method thereof, quantum dot light emitting diode and light emitting device | TCL科技集团股份有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-112250598-B | Paeonol hydrazone derivative, preparation method and application thereof, and pesticide | 河南科技大学 | 2023-07-25 | — | — | CN | disclosed |
| US-11655251-B2 | Method for the production of lumateperone and its salts | EGIS GYOGYSZERGYAR ZRT. (HU) | 2023-05-23 | — | — | US | disclosed |
| US-11655251-B2 | Method for the production of lumateperone and its salts | EGIS GYOGYSZERGYAR ZRT. (HU) | 2023-05-23 | — | — | US | disclosed |
| CN-113582910-B | Synthesis method of 1-bromocarbazole by taking carbazole as raw material | 中钢集团南京新材料研究院有限公司 | 2023-03-17 | — | — | CN | disclosed |
| US-20230009130-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2023-01-12 | — | — | US | disclosed |
| US-11485733-B2 | Azaquinoline derivatives | BAYER ANIMAL HEALTH GMBH (DE) | 2022-11-01 | — | — | US | disclosed |
| CN-112409203-B | Method for simultaneously synthesizing phenylhydrazine salt and pyruvic acid or glyoxylic acid | 帕潘纳(北京)科技有限公司 | 2022-10-25 | — | — | CN | disclosed |
| US-11453670-B2 | Substituted heterocycle fused gamma-carbolines synthesis | INTRA-CELLULAR THERAPIES, INC. (US) | 2022-09-27 | — | — | US | disclosed |
| CN-114736226-A | Method for simply preparing boron-nitrogen-pyridine compound | 南开大学 | 2022-07-12 | — | — | CN | disclosed |
| CN-114685549-A | Preparation method of novel four-coordination bisboranofluorene fluorescent compound | 南开大学 | 2022-07-01 | — | — | CN | disclosed |
| WO-2022135601-A1 | 5-ALKYL-2-PYRAZOLE-OXAZOLIDINE-4-KETONE DERIVATIVE AND USE THEREOF | 杭州百新生物医药科技有限公司 | 2022-06-30 | — | — | WO | disclosed |
| CN-109153643-B | Substituted indole MCL-1 inhibitors | 范德比尔特大学 | 2022-06-21 | — | — | CN | disclosed |
| US-20220064166-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2022-03-03 | — | — | US | disclosed |
| WO-2022040157-A1 | BORON CONTAINING COMPOUNDS AND THEIR USES | 5METIS, INC. (US) | 2022-02-24 | — | — | WO | disclosed |
| WO-2022040157-A1 | BORON CONTAINING COMPOUNDS AND THEIR USES | 5METIS, INC. (US) | 2022-02-24 | — | — | WO | disclosed |
| CN-113582910-A | Synthesis method of 1-bromocarbazole by taking carbazole as raw material | 中钢集团南京新材料研究院有限公司 | 2021-11-02 | — | — | CN | disclosed |
| EP-3898581-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | Intra-Cellular Therapies, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| EP-3898580-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | Intra-Cellular Therapies, Inc. (US) | 2021-10-27 | — | — | EP | disclosed |
| CN-113227045-A | Synthesis of substituted heterocycle fused gamma-carbolines | 细胞内治疗公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-113195450-A | Synthesis of substituted heterocycle fused gamma-carbolines | 细胞内治疗公司 | 2021-07-30 | — | — | CN | disclosed |
| CN-113121382-A | Metal compound material and preparation method thereof, quantum dot light-emitting diode and light-emitting device | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | disclosed |
| CN-112409203-A | Method for simultaneously synthesizing phenylhydrazine salt and pyruvic acid or glyoxylic acid | 帕潘纳(北京)科技有限公司 | 2021-02-26 | — | — | CN | disclosed |
| CN-112250598-A | Paeonol hydrazone derivative, preparation method and application thereof, and pesticide | 河南科技大学 | 2021-01-22 | — | — | CN | disclosed |
| EP-3756464-A1 | SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2020-12-30 | — | — | EP | disclosed |
| CN-112010798-A | Method for synthesizing N-arylcarbazole compound by catalyzing reaction of carbazole and arylhydrazine with transition metal | 新乡市润宇新材料科技有限公司 | 2020-12-01 | — | — | CN | disclosed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-20200283398-A1 | USE OF SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2020-09-10 | — | — | US | disclosed |
| WO-2020131895-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| WO-2020131911-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. (US) | 2020-06-25 | — | — | WO | disclosed |
| EP-3663294-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | Intra-Cellular Therapies, Inc. (US) | 2020-06-10 | — | — | EP | disclosed |
| US-20200131175-A1 | NEW AZAQUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2020-04-30 | — | — | US | disclosed |
| US-20200102309-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2020-04-02 | — | — | US | disclosed |
| CN-107325037-B | Preparation method of 1-bromocarbazole | 北京八亿时空液晶科技股份有限公司 | 2020-03-13 | — | — | CN | disclosed |
| US-10577327-B2 | Pyridine based ionic fluoride for catalyzing indole and tetrazole formation | KING ABDULAZIZ UNIVERSITY (SA) | 2020-03-03 | — | — | US | disclosed |
| CN-110831941-A | Synthesis of substituted heterocycle fused gamma-carboline compound | 细胞内治疗公司 | 2020-02-21 | — | — | CN | disclosed |
| EP-3609891-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | Intra-Cellular Therapies, Inc. (US) | 2020-02-19 | — | — | EP | disclosed |
| EP-2134710-B1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA CELLULAR THERAPIES INC (US) | 2020-02-12 | — | — | EP | disclosed |
| WO-2020026133-A1 | POLYCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-06 | — | — | WO | disclosed |
| EP-3604477-A1 | POLYCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | Idemitsu Kosan Co., Ltd. (JP) | 2020-02-05 | — | — | EP | disclosed |
| US-10442777-B2 | Use of substituted oxadiazoles for combating phytopathogenic fungi | BASF SE (DE) | 2019-10-15 | — | — | US | disclosed |
| US-10364256-B2 | Biaryl pyrazoles as NRF2 regulators | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-07-30 | — | — | US | disclosed |
| CN-110003160-A | A kind of Osthole hydrazone class/acylhydrazone class/sulphur acylhydrazone and preparation method thereof and application | 贵州中医药大学 | 2019-07-12 | — | — | CN | disclosed |
| WO-2019102240-A1 | METHOD FOR THE MANUFACTURE OF LUMATEPERONE AND ITS SALTS | EGIS GYÓGYSZERGYÁR ZRT. (HU) | 2019-05-31 | — | — | WO | disclosed |
| CN-106061950-B | The manufacturing method of pyrazole compound | 住友化学株式会社 | 2019-05-03 | — | — | CN | disclosed |
| US-20190119251-A1 | AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-04-25 | — | — | US | disclosed |
| EP-3452468-A1 | AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF | Bayer Pharma Aktiengesellschaft (DE) | 2019-03-13 | — | — | EP | disclosed |
| EP-2521197-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL & SUMIKIN CHEM CO (JP) | 2019-01-30 | — | — | EP | disclosed |
| US-20190016694-A1 | USE OF SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2019-01-17 | — | — | US | disclosed |
| WO-2019002132-A1 | NEW AZAQUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2019-01-03 | — | — | WO | disclosed |
| EP-1646095-B2 | Stabilised silver nanoparticles and their use | XEROX CORP (US) | 2018-10-17 | — | — | EP | disclosed |
| US-20180282349-A1 | BIARYL PYRAZOLES AS NRF2 REGULATORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2018-10-04 | — | — | US | disclosed |
| CN-108264488-A | A kind of preparation method for replacing phthalazone class compound | 天津瑞岭化工有限公司 | 2018-07-10 | — | — | CN | disclosed |
| CN-108218716-A | It is a kind of to prepare 4 '-methods of chloro- 2- aminobphenyls | 江苏澄扬作物科技有限公司 | 2018-06-29 | — | — | CN | disclosed |
| WO-2018089181-A1 | ORGANIC INDOLYL TRIARYLAMINE COMPOUNDS AND ELECTRONIC DEVICES COMPRISING AN ORGANIC LAYER CONTAINING SUCH COMPOUNDS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2018-05-17 | — | — | WO | disclosed |
| EP-3119770-B1 | NEW DIBENZOFURANS AND DIBENZOTHIOPHENES | IDEMITSU KOSAN CO (JP) | 2018-05-02 | — | — | EP | disclosed |
| EP-3112350-B1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2018-04-04 | — | — | EP | disclosed |
| US-20180044337-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. (US) | 2018-02-15 | — | — | US | disclosed |
| US-20170365789-A1 | COMPOUND, MIXTURE COMPRISING THE SAME, COMPOSITION AND ORGANIC ELECTRONIC DEVICE | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2017-12-21 | — | — | US | disclosed |
| WO-2017191105-A1 | AMIDE-SUBSTITUTED ARYLTRIAZOLE DERIVATIVES AND USES THEREOF | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2017-11-09 | — | — | WO | disclosed |
| CN-107325037-A | A kind of preparation method of 1 bromine carbazole | 北京八亿时空液晶科技股份有限公司 | 2017-11-07 | — | — | CN | disclosed |
| US-9783522-B2 | 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2017-10-10 | — | — | US | disclosed |
| US-9783522-B2 | 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2017-10-10 | — | — | US | disclosed |
| US-9751883-B2 | Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof | INTRA-CELLULAR THERAPIES, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-9751883-B2 | Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof | INTRA-CELLULAR THERAPIES, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| CN-103626766-B | With the synthesis of the heterocyclic fused γ carbolines of substitution | 细胞内治疗公司 | 2017-06-09 | — | — | CN | disclosed |
| CN-104245689-B | Terazololine-one compound and its purposes as insecticide | 住友化学株式会社 | 2017-06-06 | — | — | CN | disclosed |
| US-20170144980-A1 | USE OF SUBSTITUTED OXADIAZOLES FOR COMBATING PHYTOPATHOGENIC FUNGI | BASF SE (DE) | 2017-05-25 | — | — | US | disclosed |
| US-9624177-B2 | Method for producing pyrazole compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-04-18 | — | — | US | disclosed |
| WO-2017060854-A1 | BIARYL PYRAZOLES AS NRF2 REGULATORS | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-04-13 | — | — | WO | disclosed |
| US-20170098781-A1 | NEW DIBENZOFURANS AND DIBENZOTHIOPHENES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-06 | — | — | US | disclosed |
| US-20170098781-A1 | NEW DIBENZOFURANS AND DIBENZOTHIOPHENES | IDEMITSU KOSAN CO., LTD. (JP) | 2017-04-06 | — | — | US | disclosed |
| US-20170044133-A1 | NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2017-02-16 | — | — | US | disclosed |
| US-20170044133-A1 | NOVEL 2-AMINO-PYRIDINE AND 2-AMINO-PYRIMIDINE DERIVATIVES AND MEDICINAL USE THEREOF | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2017-02-16 | — | — | US | disclosed |
| US-9565856-B2 | Tetrazolinone compounds and its use as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-14 | — | — | US | disclosed |
| WO-2017023125-A1 | ORGANIC LIGHT-EMITTING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | 주식회사 두산 | 2017-02-09 | — | — | WO | disclosed |
| US-20170033300-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-02 | — | — | US | disclosed |
| US-20170033300-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2017-02-02 | — | — | US | disclosed |
| US-20170008853-A1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-01-12 | — | — | US | disclosed |
| EP-3112350-A1 | METHOD FOR PRODUCING PYRAZOLE COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2017-01-04 | — | — | EP | disclosed |
| CN-106061950-A | Method for producing pyrazole compound | 住友化学株式会社 | 2016-10-26 | — | — | CN | disclosed |
| US-9461250-B2 | Organic electroluminescent device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| US-9461250-B2 | Organic electroluminescent device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2016-10-04 | — | — | US | disclosed |
| EP-2499146-B1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO SA (CH) | 2016-09-21 | — | — | EP | disclosed |
| US-9434747-B2 | Methods of treating diabetes | MEDIVATION TECHNOLOGIES, INC. (US) | 2016-09-06 | — | — | US | disclosed |
| US-20160194326-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2016-07-07 | — | — | US | disclosed |
| US-20160194326-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2016-07-07 | — | — | US | disclosed |
| US-9315504-B2 | Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof | INTRA-CELLULAR THERAPIES, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| US-9315504-B2 | Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof | INTRA-CELLULAR THERAPIES, INC. (US) | 2016-04-19 | — | — | US | disclosed |
| US-9284321-B2 | Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-1-one | HOFFMANN-LA ROCHE INC. (US) | 2016-03-15 | — | — | US | disclosed |
| EP-1646095-B1 | Stabilised silver nanoparticles and their use | XEROX CORP (US) | 2016-03-09 | — | — | EP | disclosed |
| CN-105294484-A | Preparation method for 3-bromophenyl-hydrazine oxalate | TIANJIN CHEM REAGENT RES INST | 2016-02-03 | — | — | CN | disclosed |
| CN-105294485-A | Preparation method for 2-bromophenyl-hydrazine phosphate | TIANJIN CHEM REAGENT RES INST | 2016-02-03 | — | — | CN | disclosed |
| CN-105272873-A | 2-bromophenylhydrazine oxalate preparation method | TIANJIN CHEM REAGENT RES INST | 2016-01-27 | — | — | CN | disclosed |
| CN-105272876-A | 3-bromophenylhydrazine phosphate preparation method | TIANJIN CHEM REAGENT RES INST | 2016-01-27 | — | — | CN | disclosed |
| CN-105272872-A | 4-bromophenylhydrazine phosphate preparation method | TIANJIN CHEM REAGENT RES INST | 2016-01-27 | — | — | CN | disclosed |
| US-9243000-B2 | Thia-triaza-indacenes | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2016-01-26 | — | — | US | disclosed |
| CN-105198770-A | Method for preparing 4-bromophenylhydrazine oxalate | TIANJIN CHEM REAGENT RES INST | 2015-12-30 | — | — | CN | disclosed |
| US-9193728-B2 | Fused tetracyclic pyrido [4,3-B] indole and pyrido [3,4-B] indole derivatives and methods of use | MEDIVATION TECHNOLOGIES, INC. (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2015140073-A1 | NEW DIBENZOFURANS AND DIBENZOTHIOPHENES | IDEMITSU KOSAN CO., LTD. (JP) | 2015-09-24 | — | — | WO | disclosed |
| US-20150246922-A1 | PIPERAZINO[1,2-A]INDOL-1-ONES AND [1,4]DIAZEPINO[1,2-A]INDOL-1-ONE | HOFFMANN-LA ROCHE INC. (US) | 2015-09-03 | — | — | US | disclosed |
| CN-102695710-B | Tricyclic pyrazole sulfonamide derivatives | MERCK SERONO S.A. (CH) | 2015-08-19 | — | — | CN | disclosed |
| US-9073940-B2 | Tricyclic pyrazol amine derivatives | MERCK SERONO SA (CH) | 2015-07-07 | — | — | US | disclosed |
| EP-2421872-B1 | THIA-TRIAZA-AS-INDACENES AS PI3-KINASES INHIBITORS FOR THE TREATMENT OF CANCER | BOEHRINGER INGELHEIM INT (DE) | 2015-06-10 | — | — | EP | disclosed |
| US-9040704-B2 | Fluorescent dyes with large stokes shifts | UTI LIMITED PARTNERSHIP (CA) | 2015-05-26 | — | — | US | disclosed |
| CN-104592128-A | SUBSTITUTED CINNOLINE DERIVATIVES AS GABAA-RECEPTOR MODULATORS AND METHOD FOR THEIR SYNTHESIS | ASTRAZENECA AB | 2015-05-06 | — | — | CN | disclosed |
| CN-102087892-B | Ultra low melt metal nanoparticle composition and method of forming conductive features by using the same | XEROX CORP | 2015-04-08 | — | — | CN | disclosed |
| US-8986858-B2 | Organic electroluminescent device | NIPPON STEEL & SUMIKIN CHEMICAL CO., LTD. (JP) | 2015-03-24 | — | — | US | disclosed |
| EP-2841429-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | Sumitomo Chemical Company Limited (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-20150051171-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-19 | — | — | US | disclosed |
| US-8940197-B2 | Processes for producing palladium nanoparticle inks | XEROX CORPORATION (US) | 2015-01-27 | — | — | US | disclosed |
| US-20140377457-A1 | METHOD OF FORMING METAL NANOPARTICLE DISPERSION AND DISPERSION FORMED THEREBY | XEROX CORPORATION | 2014-12-25 | — | — | US | disclosed |
| CN-104245689-A | Tetrazolinone compounds and its use as pesticides | SUMITOMO CHEMICAL CO | 2014-12-24 | — | — | CN | disclosed |
| US-20140364609-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2014-12-11 | — | — | US | disclosed |
| US-20140364609-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2014-12-11 | — | — | US | disclosed |
| US-20140303144-A1 | COMPOUNDS AND METHODS OF TREATING HYPERTENSION | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-10-09 | — | — | US | disclosed |
| US-20140228353-A1 | COMPOUNDS AND METHODS OF TREATING DIABETES | MEDIVATION TECHNOLOGIES, INC. (US) | 2014-08-14 | — | — | US | disclosed |
| CN-103080085-B | Novel crystalline forms of 4, 4' - [ 4-fluoro-7- ({4- [4- (3-fluoro-2-methylphenyl) butoxy ] phenyl } ethynyl) -2-methyl-1H-indole-1, 3-diyl ] dibutanoic acid | ONO PHARMACEUTICAL CO | 2014-08-13 | — | — | CN | disclosed |
| US-20140206870-A1 | FLUORSCENT DYES WITH LARGE STOKES SHIFTS | UTI LIMITED PARTNERSHIP (CA) | 2014-07-24 | — | — | US | disclosed |
| US-8779139-B2 | Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof | INTRA-CELLULAR THERAPIES, INC. | 2014-07-15 | — | — | US | disclosed |
| US-8779139-B2 | Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof | INTRA-CELLULAR THERAPIES, INC. | 2014-07-15 | — | — | US | disclosed |
| CN-101720317-B | Process for producing difluoromethyl-substituted pyrazole compound | BASF SE | 2014-07-09 | — | — | CN | disclosed |
| WO-2014104665-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | 주식회사 두산 (KR) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014104665-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT ELEMENT INCLUDING SAME | 주식회사 두산 (KR) | 2014-07-03 | — | — | WO | disclosed |
| CN-101643201-B | Silver nanoparticle process | XEROX CORP | 2014-05-28 | — | — | CN | disclosed |
| CN-103626766-A | Substituted heterocycle fused gamma-carbolines synthesis | INTRA CELLULAR THERAPIES INC | 2014-03-12 | — | — | CN | disclosed |
| CN-101653828-B | Silver nanoparticles and process for producing same | XEROX CORP | 2014-02-26 | — | — | CN | disclosed |
| CN-103408455-A | Preparation method of 2-bromophenylhydrazine sulfate | TIANJIN CHEM REAGENT RES INST | 2013-11-27 | — | — | CN | disclosed |
| CN-103396337-A | Preparation method of 3-bromohydrazinobenzene hydrochloride | TIANJIN CHEM REAGENT RES INST | 2013-11-20 | — | — | CN | disclosed |
| CN-103396336-A | Preparation method of 3-bromohydrazinobenzene sulfate | TIANJIN CHEM REAGENT RES INST | 2013-11-20 | — | — | CN | disclosed |
| CN-103387513-A | Preparation method of 4-bromophenylhydrazine sulfate | TIANJIN CHEM REAGENT RES INST | 2013-11-13 | — | — | CN | disclosed |
| CN-103387514-A | Preparation method of 2-bromophenylhydrazine hydrochloride | TIANJIN CHEM REAGENT RES INST | 2013-11-13 | — | — | CN | disclosed |
| CN-103387515-A | Preparation method of 4-bromophenylhydrazine hydrochloride | TIANJIN CHEM REAGENT RES INST | 2013-11-13 | — | — | CN | disclosed |
| CN-101796051-B | Synthesis of substituted heterocycle fused gamma-carbolines | INTRA CELLULAR THERAPIES INC | 2013-11-06 | — | — | CN | disclosed |
| WO-2013162072-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-31 | — | — | WO | disclosed |
| CN-102186818-B | 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases | BOEHRINGER INGELHEIM INT | 2013-10-02 | — | — | CN | disclosed |
| EP-2161087-B1 | Silver nanoparticle process | XEROX CORP (US) | 2013-09-11 | — | — | EP | disclosed |
| US-20130221288-A1 | PROCESSES FOR PRODUCING PALLADIUM NANOPARTICLE INKS | XEROX CORPORATION (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130210803-A1 | FUSED TETRACYCLIC PYRIDO [4,3-B] INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE | MEDIVATION TECHNOLOGIES, INC. | 2013-08-15 | — | — | US | disclosed |
| CN-103224470-A | Preparation method and application of quinoxaline-6-phenylhydrazone derivants | UNIV NANJING AGRICULTURAL | 2013-07-31 | — | — | CN | disclosed |
| CN-103080085-A | 4,4 ' - [ 4-fluoro-7- ({4- [4- (3-fluoro-2-methylphenyl) butoxy ] phenyl } ethynyl) -2-methyl-1H-indole-1, 3-diyl ] dibutanoic acid, 4 ' - [ 2-methyl-7- ({4- [4- (pentafluorophenyl) butoxy ] phenyl } ethynyl) -1H-indole-1, 3-diyl ] dibutanoic acid and 4,4 ' - [ 4-fluoro-2-methyl-7 | ONO PHARMACEUTICAL CO | 2013-05-01 | — | — | CN | disclosed |
| US-8431590-B2 | Spiroindolines as modulators of chemokine receptors | GLAXO GROUP LIMITED (GB) | 2013-04-30 | — | — | US | disclosed |
| CN-101759628-B | Ethynylindole compounds | ONO PHARMACEUTICAL CO | 2013-02-27 | — | — | CN | disclosed |
| US-8382878-B2 | Silver nanoparticle process | XEROX CORPORATION (US) | 2013-02-26 | — | — | US | disclosed |
| US-20130046097-A1 | SUBSTITUTED HETEROCYCLE GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2013-02-21 | — | — | US | disclosed |
| US-20130046097-A1 | SUBSTITUTED HETEROCYCLE GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. | 2013-02-21 | — | — | US | disclosed |
| WO-2013023292-A1 | FLUORESCENT DYES WITH LARGE STOKES SHIFTS | UTI LIMITED PARTNERSHIP (CA) | 2013-02-21 | — | — | WO | disclosed |
| EP-2156911-B1 | Silver nanoparticles and process for producing same | XEROX CORP (US) | 2013-02-20 | — | — | EP | disclosed |
| EP-2170879-B1 | 1-CYANOCYCLOPROPYL-DERIVATIVES AS CATHEPSIN K INHIBITORS | ASTRAZENECA AB (SE) | 2013-01-16 | — | — | EP | disclosed |
| US-20120319095-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-12-20 | — | — | US | disclosed |
| US-8309722-B2 | Substituted heterocycle gamma-carbolines synthesis | INTRA-CELLULAR THERAPIES, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309722-B2 | Substituted heterocycle gamma-carbolines synthesis | INTRA-CELLULAR THERAPIES, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| EP-2521197-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel Chemical Co., Ltd. (JP) | 2012-11-07 | — | — | EP | disclosed |
| US-8304556-B2 | Thiazolyl-dihydro-indazoles | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-11-06 | — | — | US | disclosed |
| US-8298314-B2 | Silver nanoparticles and process for producing same | XEROX CORPORATION (US) | 2012-10-30 | — | — | US | disclosed |
| CN-102695710-A | Tricyclic pyrazol amine derivatives | MERCK SERONO SA | 2012-09-26 | — | — | CN | disclosed |
| US-20120238545-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO SA (CH) | 2012-09-20 | — | — | US | disclosed |
| US-20120235136-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2012-09-20 | — | — | US | disclosed |
| US-20120235136-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2012-09-20 | — | — | US | disclosed |
| EP-2499146-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | Merck Serono S.A. (CH) | 2012-09-19 | — | — | EP | disclosed |
| US-8242278-B2 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-08-14 | — | — | US | disclosed |
| EP-2206698-B1 | Ethynylindole compounds | ONO PHARMACEUTICAL CO (JP) | 2012-07-18 | — | — | EP | disclosed |
| US-8188295-B2 | Method for producing difluoromethyl-substituted pyrazole compounds | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| WO-2012065062-A1 | NOVEL ANTIVIRAL COMPOUNDS | PHARMARESOURCES(SHANGHAI)CO., LTD. (CN) | 2012-05-18 | — | — | WO | disclosed |
| US-20120108567-A1 | Thiazolyl-Dihydro-Indazoles | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-05-03 | — | — | US | disclosed |
| US-20120108618-A1 | THIA-TRIAZA-INDACENES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-05-03 | — | — | US | disclosed |
| US-20120101278-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | HAGIYA KOJI (JP) | 2012-04-26 | — | — | US | disclosed |
| US-8147908-B2 | Increased throughput for large-scale production of low melt organoamine stabilized silver nano-particles | XEROX CORPORATION (US) | 2012-04-03 | — | — | US | disclosed |
| EP-2326649-B1 | NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS | CENTRE NAT RECH SCIENT (FR) | 2012-03-28 | — | — | EP | disclosed |
| EP-2323980-B1 | 7-(PIPERAZINE-1-YMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID (PHENYL)-AMIDE DERIVATIVES AND ALLIED COMPOUNDS AS P38 MAP KINASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES | BOEHRINGER INGELHEIM INT (DE) | 2012-02-29 | — | — | EP | disclosed |
| US-8088768-B2 | Protein kinase and phosphatase inhibitors | THE RESEARCH FOUNDATION OF THE STATE UNIVERSITY OF NEW YORK (US) | 2012-01-03 | — | — | US | disclosed |
| US-20110305826-A1 | INCREASED THROUGHPUT FOR LARGE-SCALE PRODUCTION OF LOW MELT ORGANOAMINE STABILIZED SILVER NANO-PARTICLES | XEROX CORPORATION (US) | 2011-12-15 | — | — | US | disclosed |
| US-8057849-B2 | Ultra low melt metal nanoparticle composition for thick-film applications | XEROX CORPORATION (US) | 2011-11-15 | — | — | US | disclosed |
| US-20110269737-A1 | 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110269737-A1 | 7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-11-03 | — | — | US | disclosed |
| US-20110269763-A1 | CRTH2 receptor ligands for medicinal uses | 7TM PHARMA A/S (DK) | 2011-11-03 | — | — | US | disclosed |
| US-8022063-B2 | CRTH2 receptor ligands for medicinal uses | 7TM PHARMA A/S (DK) | 2011-09-20 | — | — | US | disclosed |
| CN-102186818-A | 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases | BOEHRINGER INGELHEIM INT | 2011-09-14 | — | — | CN | disclosed |
| CN-102171213-A | Pyrazolo [3, 4] pyrimidin-4-yl derivatives and their uses to treat diabetes and obesity | ASTRAZENECA AB | 2011-08-31 | — | — | CN | disclosed |
| US-8008279-B2 | Compound—827 | ASTRAZENECA AB (SE) | 2011-08-30 | — | — | US | disclosed |
| EP-2158185-B1 | METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED PYRAZOLE COMPOUNDS | BASF SE (DE) | 2011-08-17 | — | — | EP | disclosed |
| EP-2336113-A1 | CRTH2 Receptor Ligands for Medical Use | 7TM Pharma A/S (DK) | 2011-06-22 | — | — | EP | disclosed |
| US-20110135808-A1 | ULTRA LOW MELT METAL NANOPARTICLE COMPOSITION FOR THICK-FILM APPLICATIONS | XEROX CORPORATION (US) | 2011-06-09 | — | — | US | disclosed |
| US-20110136807-A1 | Bicyclic compositions and methods for modulating a kinase cascade | KINEX PHARMACEUTICALS, LLC (US) | 2011-06-09 | — | — | US | disclosed |
| CN-102087892-A | Ultra low melt metal nanoparticle composition and method of forming conductive features by using the same | XEROX CORP | 2011-06-08 | — | — | CN | disclosed |
| EP-2326649-A1 | NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS | Centre National de la Recherche Scientifique (FR) | 2011-06-01 | — | — | EP | disclosed |
| EP-2323980-A1 | 7-(PIPERAZINE-1-YMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID (PHENYL)-AMIDE DERIVATIVES AND ALLIED COMPOUNDS AS P38 MAP KINASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES | Boehringer Ingelheim International GmbH (DE) | 2011-05-25 | — | — | EP | disclosed |
| WO-2011058149-A1 | TRICYCLIC PYRAZOL AMINE DERIVATIVES | MERCK SERONO S.A. (CH) | 2011-05-19 | — | — | WO | disclosed |
| US-20110118208-A1 | Thiazolyl-Dihydro-Indazoles | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-05-19 | — | — | US | disclosed |
| CN-102009184-A | Method for preparing metal nanoparticles, composition thereof and process of forming metal frame | XEROX CORP | 2011-04-13 | — | — | CN | disclosed |
| US-20110059233-A1 | Method For Preparing Stabilized Metal Nanoparticles | XEROX CORPORATION (US) | 2011-03-10 | — | — | US | disclosed |
| US-20110034499-A1 | SPIROINDOLINES AS MODULATORS OF CHEMOKINE RECEPTORS | GLAXO GROUP LIMITED (GB) | 2011-02-10 | — | — | US | disclosed |
| US-20110028474-A1 | PROTEIN KINASE AND PHOSPHATASE INHIBITORS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2011-02-03 | — | — | US | disclosed |
| US-7838542-B2 | Bicyclic compositions and methods for modulating a kinase cascade | KINEX PHARMACEUTICALS, LLC (US) | 2010-11-23 | — | — | US | disclosed |
| US-7772216-B2 | Protein kinase and phosphatase inhibitors and methods for designing them | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2010-08-10 | — | — | US | disclosed |
| CN-101796051-A | Synthesis of substituted heterocycle fused gamma-carbolines | INTRA CELLULAR THERAPIES INC | 2010-08-04 | — | — | CN | disclosed |
| US-20100184994-A1 | Method for Producing Difluoromethyl-Substituted Pyrazole Compounds | BASF SE (DE) | 2010-07-22 | — | — | US | disclosed |
| EP-2206698-A1 | Ethynylindole compounds | ONO Pharmaceutical Co., Ltd. (JP) | 2010-07-14 | — | — | EP | disclosed |
| CN-101759628-A | Ethynylindole compounds | ONO PHARMACEUTICAL CO | 2010-06-30 | — | — | CN | disclosed |
| CN-101720317-A | Process for producing difluoromethyl-substituted pyrazole compound | BASF SE | 2010-06-02 | — | — | CN | disclosed |
| US-7723350-B2 | Spiroindolines as modulators of chemokine receptors | GLAXO GROUP LIMITED (GB) | 2010-05-25 | — | — | US | disclosed |
| US-20100113781-A1 | SUBSTITUTED HETEROCYCLE GAMMA-CARBOLINES SYNTHESIS | INTRACELLULAR THERAPIES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-20100113781-A1 | SUBSTITUTED HETEROCYCLE GAMMA-CARBOLINES SYNTHESIS | INTRACELLULAR THERAPIES, INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-7700595-B2 | such as 3-benzyl-4-phenyl-8-(trifluoromethyl)cinnoline; modulators of Liver X receptors (LXRs) | WYETH LLC (US) | 2010-04-20 | — | — | US | disclosed |
| EP-2170879-A1 | 1-CYANOCYCLOPROPYL-DERIVATIVES AS CATHEPSIN K INHIBITORS | AstraZeneca AB (SE) | 2010-04-07 | — | — | EP | disclosed |
| CN-101692419-A | Methods of printing conductive silver features | XEROX CORP | 2010-04-07 | — | — | CN | disclosed |
| CN-101687864-A | 1-cyanocyclopropyl-derivatives as cathepsin K inhibitors | ASTRAZENECA AB | 2010-03-31 | — | — | CN | disclosed |
| WO-2010026096-A1 | 7-(PIPERAZINE-1-YMETHYL)-1H-INDOLE-2-CARBOXYLIC ACID (PHENYL)-AMIDE DERIVATIVES AND ALLIED COMPOUNDS AS P38 MAP KINASE INHIBITORS FOR THE TREATMENT OF RESPIRATORY DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-03-11 | — | — | WO | disclosed |
| EP-2161087-A1 | Silver nanoparticle process | Xerox Corporation (US) | 2010-03-10 | — | — | EP | disclosed |
| EP-2158185-A2 | METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED PYRAZOLE COMPOUNDS | Basf Se (DE) | 2010-03-03 | — | — | EP | disclosed |
| EP-2156911-A1 | Silver nanoparticles and process for producing same | Xerox Corporation (US) | 2010-02-24 | — | — | EP | disclosed |
| CN-101653828-A | Silver nanoparticles and process for producing same | XEROX CORP | 2010-02-24 | — | — | CN | disclosed |
| US-20100037731-A1 | SILVER NANOPARTICLES AND PROCESS FOR PRODUCING SAME | XEROX CORPORATION (US) | 2010-02-18 | — | — | US | disclosed |
| US-20100034693-A1 | SILVER NANOPARTICLE PROCESS | XEROX CORPORATION (US) | 2010-02-11 | — | — | US | disclosed |
| CN-101643201-A | Silver nanoparticle process | XEROX CORP | 2010-02-10 | — | — | CN | disclosed |
| WO-2009001129-A9 | 1-CYANOCYCLOPROPYL-DERIVATIVES AS CATHEPSIN K INHIBITORS | ASTRAZENECA AB (SE) | 2010-02-04 | — | — | WO | disclosed |
| WO-2010012397-A1 | N-(INDOL-3-YLALKYL)(HETERO)ARYLAMIDE DERIVATIVES AS MODULATORS OF THE EP2 RECEPTOR | BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) | 2010-02-04 | — | — | WO | disclosed |
| EP-2149551-A1 | N-(indol-3-ylalkyl)-(hetero)arylamid derivatives as modulators of EP2 receptors | Bayer Schering Pharma AG (DE) | 2010-02-03 | — | — | EP | disclosed |
| WO-2010000978-A1 | NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-01-07 | — | — | WO | disclosed |
| CN-101591281-A | Phosphonate compounds having immunomodulatory activity | GILEAD SCIENCES INC (US) | 2009-12-02 | — | — | CN | disclosed |
| EP-1473286-B1 | PROCESS FOR PRODUCING BIARYL COMPOUND | SUMITOMO CHEMICAL CO (JP) | 2009-11-04 | — | — | EP | disclosed |
| EP-2108012-A2 | SUBSTITUTED N-(4-CYANO-1H-PYRAZOL-3-YL)METHYLAMINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | Sanofi-Aventis (FR) | 2009-10-14 | — | — | EP | disclosed |
| US-20090247488-A1 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | CANNIZZARO CARINA | 2009-10-01 | — | — | US | disclosed |
| US-20090247488-A1 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | CANNIZZARO CARINA | 2009-10-01 | — | — | US | disclosed |
| US-20090247488-A1 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | CANNIZZARO CARINA | 2009-10-01 | — | — | US | disclosed |
| US-20090227543-A1 | PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY | CANNIZZARO CARINA | 2009-09-10 | — | — | US | disclosed |
| US-20090227543-A1 | PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY | CANNIZZARO CARINA | 2009-09-10 | — | — | US | disclosed |
| US-20090227543-A1 | PHOSPHONATE COMPOUNDS HAVING IMMUNO-MODULATORY ACTIVITY | CANNIZZARO CARINA | 2009-09-10 | — | — | US | disclosed |
| EP-2098316-A2 | Metal nanoparticles stabilized with a bident amine | Xerox Corporation (US) | 2009-09-09 | — | — | EP | disclosed |
| US-7582773-B2 | Substituted phenyl indoles | WYETH (US) | 2009-09-01 | — | — | US | disclosed |
| US-20090214764-A1 | METAL NANOPARTICLES STABILIZED WITH A BIDENT AMINE | XEROX CORPORATION (US) | 2009-08-27 | — | — | US | disclosed |
| US-20090216017-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | HAGIYA KOJI | 2009-08-27 | — | — | US | disclosed |
| US-7554000-B2 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-06-30 | — | — | US | disclosed |
| US-20090148600-A1 | Metal Nanoparticles Stabilized With a Carboxylic Acid-Organoamine Complex | XEROX CORPORATION (US) | 2009-06-11 | — | — | US | disclosed |
| US-20090142482-A1 | Methods of Printing Conductive Silver Features | XEROX CORPORATION (US) | 2009-06-04 | — | — | US | disclosed |
| WO-2009065181-A1 | NANOSTRUCTURES SUITABLE FOR DELIVERY OF AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2009-05-28 | — | — | WO | disclosed |
| US-20090099189-A1 | CRTH2 Receptor Ligands For Medicinal Uses | 7TM PHARMA A/S (DK) | 2009-04-16 | — | — | US | disclosed |
| CN-101410120-A | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES INC (US) | 2009-04-15 | — | — | CN | disclosed |
| EP-2038254-A2 | BICYCLIC COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE | Kinex Pharmaceuticals, LLC (US) | 2009-03-25 | — | — | EP | disclosed |
| EP-1319659-B1 | TRIAZINONES AND MEDICINAL USE THEREOF | EISAI R&D MAN CO LTD (JP) | 2009-03-11 | — | — | EP | disclosed |
| US-7501512-B2 | Chemical compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2009-03-10 | — | — | US | disclosed |
| CN-101379042-A | Substituted cinnoline derivatives as GABAA receptor modulators and methods of synthesis thereof | ASTRAZENECA AB (SE) | 2009-03-04 | — | — | CN | disclosed |
| US-7494608-B2 | Stabilized silver nanoparticle composition | XEROX CORPORATION (US) | 2009-02-24 | — | — | US | disclosed |
| US-20090012077-A1 | Novel Compound - 827 | ASTRAZENECA AB (SE) | 2009-01-08 | — | — | US | disclosed |
| WO-2009001129-A1 | 1-CYANOCYCLOPROPYL-DERIVATIVES AS CATHEPSIN K INHIBITORS | ASTRAZENECA AB (SE) | 2008-12-31 | — | — | WO | disclosed |
| US-7470724-B2 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470724-B2 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. (US) | 2008-12-30 | — | — | US | disclosed |
| US-7470724-B2 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. (US) | 2008-12-30 | — | — | US | disclosed |
| US-20080318990-A1 | SPIROINDOLINES AS MODULATORS OF CHEMOKINE RECEPTORS | GLAXO GROUP LIMITED (GB) | 2008-12-25 | — | — | US | disclosed |
| WO-2008152138-A2 | METHOD FOR PRODUCING DIFLUOROMETHYL-SUBSTITUTED PYRAZOLE COMPOUNDS | BASF SE (DE) | 2008-12-18 | — | — | WO | disclosed |
| EP-1984355-A2 | CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION | Takeda Pharmaceutical Company Limited (JP) | 2008-10-29 | — | — | EP | disclosed |
| US-7432261-B2 | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432261-B2 | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-7432261-B2 | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES, INC. (US) | 2008-10-07 | — | — | US | disclosed |
| US-7427608-B2 | Protection against and treatment of hearing loss | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2008-09-23 | — | — | US | disclosed |
| WO-2008112280-A1 | SUBSTITUTED HETEROCYCLE FUSED GAMMA-CARBOLINES SYNTHESIS | INTRA-CELLULAR THERAPIES, INC. (US) | 2008-09-18 | — | — | WO | disclosed |
| WO-2008099076-A2 | SUBSTITUTED N-(4-CYANO-1H-PYRAZOL-3-YL)METHYLAMINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF | SANOFI-AVENTIS (FR) | 2008-08-21 | — | — | WO | disclosed |
| CN-101238107-A | Novel cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation | GLENMARK PHARMACEUTICALS SA (CH) | 2008-08-06 | — | — | CN | disclosed |
| CN-101148420-A | Preparation method for 2-bromophenylhydrazine | TAICHANG HUALIAN CHEMICAL INDU (CN) | 2008-03-26 | — | — | CN | disclosed |
| CN-101148420-A | Preparation method for 2-bromophenylhydrazine | TAICHANG HUALIAN CHEMICAL INDU (CN) | 2008-03-26 | — | — | CN | disclosed |
| US-20080009480-A1 | CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES | WYETH (US) | 2008-01-10 | — | — | US | disclosed |
| US-20080000382-A1 | STABILIZED SILVER NANOPARTICLE COMPOSITION | XEROX CORPORATION (US) | 2008-01-03 | — | — | US | disclosed |
| US-20080004241-A1 | 2-carboxamide substituted indoles; osteoporosis, hepatitis B, ophthalmic disease, diabetes, atherosclerosis, obesity, chronic neuropathic pain, stroke; protein tyrosine kinase (PTK) inhibitors; 5-fluoro-3-phenylindole-2-carboxamides | OAKTREE FUND ADMINISTRATION, LLC | 2008-01-03 | — | — | US | disclosed |
| WO-2008002674-A2 | BICYCLIC COMPOSITIONS AND METHODS FOR MODULATING A KINASE CASCADE | KINEX PHARMACEUTICALS, LLC (US) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007131286-A1 | NANOSTRUCTURES SUITABLE FOR DELIVERY OF AGENTS | APOLLO LIFE SCIENCES LIMITED (AU) | 2007-11-22 | — | — | WO | disclosed |
| EP-1853566-A1 | CINNOLINE COMPOUNDS AND THEIR USE AS LIVER X RECEPTOR MODULATORS | Wyeth (US) | 2007-11-14 | — | — | EP | disclosed |
| EP-1851219-A1 | FUSED HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF HISTONE DEACETYLASE | Miikana Therapeutics, Inc. (US) | 2007-11-07 | — | — | EP | disclosed |
| US-7271163-B2 | Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives | WYETH (US) | 2007-09-18 | — | — | US | disclosed |
| US-7270694-B2 | Stabilized silver nanoparticles and their use | XEROX CORPORATION (US) | 2007-09-18 | — | — | US | disclosed |
| EP-1824821-A2 | CARBAZOLE, CARBOLINE AND INDOLE DERIVATIVES USEFUL IN THE INHIBITION OF VEGF PRODUCTION | PTC Therapeutics, Inc. (US) | 2007-08-29 | — | — | EP | disclosed |
| WO-2007094513-A2 | CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-08-23 | — | — | WO | disclosed |
| US-20070099357-A1 | DEVICES CONTAINING ANNEALED STABILIZED SILVER NANOPARTICLES | XEROX CORPORATION (US) | 2007-05-03 | — | — | US | disclosed |
| EP-1758579-A1 | CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES | 7TM Pharma A/S (DK) | 2007-03-07 | — | — | EP | disclosed |
| US-20060252757-A1 | Cinnoline compounds | WYETH | 2006-11-09 | — | — | US | disclosed |
| US-7129225-B2 | Protection against and treatment of hearing loss | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2006-10-31 | — | — | US | disclosed |
| WO-2006094034-A1 | CINNOLINE COMPOUNDS AND THEIR USE AS LIVER X RECEPTOR MODILATORS | WYETH (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20060199788-A1 | Anti-inflammatory phosphonate compounds | GILEAD SCIENCES, INC. | 2006-09-07 | — | — | US | disclosed |
| WO-2006088949-A1 | FUSED HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF HISTONE DEACETYLASE | MIIKANA THERAPEUTICS, INC. (US) | 2006-08-24 | — | — | WO | disclosed |
| US-20060189622-A1 | Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2006-08-24 | — | — | US | disclosed |
| US-20060178384-A1 | 2-(2,6-dimethoxy-phenylamino)-9-methoxy-6,7-dihydro-pyrimido[6,1-a]isoquinolin-4-one; 3-bromo-N-[3-(9-methoxy-4-oxo-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-2-ylamino)-phenyl]-benzamide; kinase inhibitor; neutropenia; cytopenia; anemias | SMITHKLINE BEECHAM CORPORATION | 2006-08-10 | — | — | US | disclosed |
| US-20060172971-A1 | Protection against and treatment of hearing loss | NICOTERA THOMAS | 2006-08-03 | — | — | US | disclosed |
| EP-1663254-A2 | ANTI-INFLAMATORY PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2006-06-07 | — | — | EP | disclosed |
| WO-2006058088-A2 | CARBAZOLE, CARBOLINE AND INDOLE DERIVATIVES USEFUL IN THE INHIBITION OF VEGF PRODUCTION | PTC THERAPEUTICS, INC. (US) | 2006-06-01 | — | — | WO | disclosed |
| CN-1780630-A | Phosphonate compounds having immunomodulatory activity | GILEAD SCIENCES INC (US) | 2006-05-31 | — | — | CN | disclosed |
| EP-1646095-A2 | Stabilised silver nanoparticles and their use | Xerox Corporation (US) | 2006-04-12 | — | — | EP | disclosed |
| US-20060073667-A1 | Stabilized silver nanoparticles and their use | XEROX CORPORATION | 2006-04-06 | — | — | US | disclosed |
| EP-1641766-A2 | NOVEL CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2006-04-05 | — | — | EP | disclosed |
| US-7005445-B2 | Protein kinase and phosphatase inhibitors and methods for designing them | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2006-02-28 | — | — | US | disclosed |
| US-20060035866-A1 | Phosphonate compounds having immuno-modulatory activity | GILEAD SCIENCES, INC. | 2006-02-16 | — | — | US | disclosed |
| US-20060030544-A1 | Protein kinase and phosphatase inhibitors and methods for designing them | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE | 2006-02-09 | — | — | US | disclosed |
| EP-1620110-A2 | IMMUNOMODULATOR PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2006-02-01 | — | — | EP | disclosed |
| US-20060009445-A1 | Tumor-inhibiting anellated azepinone derivatives | FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH | 2006-01-12 | — | — | US | disclosed |
| WO-2005115382-A1 | CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES | 7TM PHARMA A/S (DK) | 2005-12-08 | — | — | WO | disclosed |
| EP-1414819-B1 | THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES | PHARMACIA & UPJOHN CO LLC (US) | 2005-10-12 | — | — | EP | disclosed |
| CN-1680334-A | Fused pyrazolyls | YUNG SHIN PHARM IND CO LTD (CN) | 2005-10-12 | — | — | CN | disclosed |
| EP-1581534-A2 | TUMOUR-INHIBITING ANNELLATED AZEPINONE DERIVATIVES | Faustus Forschungs Cie. Translational Cancer Research GmbH (DE) | 2005-10-05 | — | — | EP | disclosed |
| CN-1214007-C | Cyclopentaindoles, compositions containing such compounds, and methods of treatment | MERCK FROSST CANADA INC (CA) | 2005-08-10 | — | — | CN | disclosed |
| US-20050096471-A1 | Process for producing biaryl compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-05-05 | — | — | US | disclosed |
| US-20050070592-A1 | Substituted phenyl indoles | WYETH (US) | 2005-03-31 | — | — | US | disclosed |
| US-6849640-B2 | Therapeutic 1H-pyrido [4,3-b] indoles | PHARMACIA & UPJOHN COMPANY (US) | 2005-02-01 | — | — | US | disclosed |
| WO-2005007092-A2 | NOVEL CHEMICAL COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2005-01-27 | — | — | WO | disclosed |
| EP-1305286-B1 | CYCLOPENTANOINDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK FROSST CANADA INC (CA) | 2004-12-08 | — | — | EP | disclosed |
| WO-2004100960-A2 | ANTI-INFLAMMATORY PHOSPHONATE COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-11-25 | — | — | WO | disclosed |
| WO-2004096236-A2 | IMMUNOMODULATOR PHOSPHONATE CONJUGATES | GILEAD SCIENCES, INC. (US) | 2004-11-11 | — | — | WO | disclosed |
| EP-1473286-A1 | PROCESS FOR PRODUCING BIARYL COMPOUND | Sumitomo Chemical Company, Limited (JP) | 2004-11-03 | — | — | EP | disclosed |
| US-6777407-B2 | 7BH-CYCLOPENTA(B)(1,4)DIAZEPINO(6, 7, 1-HI)INDOLE OR A SALT, USEFUL FOR TREATMENT OF SCHIZOPHRENIA, OBSESSIVE COMPULSIVE DISORDER, DEPRESSION, ANXIETY, PANIC DISORDER, OBESITY OR EPILEPSY | WYETH | 2004-08-17 | — | — | US | disclosed |
| EP-1444204-A1 | PROTEIN KINASE AND PHOSPHATASE INHIBITORS, METHODS FOR DESIGNING THEM, AND METHODS OF USING THEM | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2004-08-11 | — | — | EP | disclosed |
| WO-2004058766-A2 | TUMOUR-INHIBITING ANNELLATED AZEPINONE DERIVATIVES | FAUSTUS FORSCHUNGS CIE. TRANSLATIONAL CANCER RESEARCH GMBH (DE) | 2004-07-15 | — | — | WO | disclosed |
| US-6753334-B2 | PREPARING A PHENYL OR QUINOLINYL HYDRAZINE BY REDUCING THE CORRESPONDING DIAZONIUM SALT WITH ASCORBIC ACID AND HEATING; COLORLESS PRODUCT; INTERMEDIATES TO DRUGS FOR REDUCING TISSUE DAMAGE FROM ISCHEMIA OR HYPOXIA | PFIZER, INC. | 2004-06-22 | — | — | US | disclosed |
| EP-1414819-A1 | THERAPEUTIC 1H-PYRIDO 4,3-b]INDOLES | PHARMACIA & UPJOHN COMPANY (US) | 2004-05-06 | — | — | EP | disclosed |
| EP-1042319-B1 | DIHYDROBENZOFURANS | ALTANA PHARMA AG (DE) | 2004-02-04 | — | — | EP | disclosed |
| US-20040019015-A1 | Protection against and treatment of hearing loss | HEALTH RESEARCH, INC. (ROSWELL PARK DIVISION) | 2004-01-29 | — | — | US | disclosed |
| EP-1377621-A2 | SILICONE LIQUID CRYSTALS, VESICLES, AND GELS | Dow Corning Corporation (US) | 2004-01-07 | — | — | EP | disclosed |
| US-20030225081-A1 | Pyridazinones and triazinones and medicinal use thereof | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2003-12-04 | — | — | US | disclosed |
| CN-1443165-A | Cyclopentaindoles, compositions containing such compounds, and methods of treatment | MERCK FROSST CANADA INC (CA) | 2003-09-17 | — | — | CN | disclosed |
| US-20030166615-A1 | Protein kinase and phosphatase inhibitors and methods for designing them | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE | 2003-09-04 | — | — | US | disclosed |
| EP-1337508-A1 | PREPARATION OF SODIUM-HYDROGEN EXCHANGER TYPE-1 INHIBITORS | Pfizer Products Inc. (US) | 2003-08-27 | — | — | EP | disclosed |
| EP-1319659-A1 | PYRIDAZINONES AND TRIAZINONES AND MEDICINAL USE THEREOF | Eisai Co., Ltd. (JP) | 2003-06-18 | — | — | EP | disclosed |
| EP-1305286-A2 | CYCLOPENTANOINDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK FROSST CANADA INC. (CA) | 2003-05-02 | — | — | EP | disclosed |
| WO-2003035621-A1 | PROTEIN KINASE AND PHOSPHATASE INHIBITORS, METHODS FOR DESIGNING THEM, AND METHODS OF USING THEM | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2003-05-01 | — | — | WO | disclosed |
| US-20030060464-A1 | Therapeutic 1H-pyrido [ 4, 3-b ] indoles | PHARMACIA & UPJOHN COMPANY | 2003-03-27 | — | — | US | disclosed |
| WO-2003014118-A1 | THERAPEUTIC 1H-PYRIDO[4,3-b]INDOLES | PHARMACIA & UPJOHN COMPANY (US) | 2003-02-20 | — | — | WO | disclosed |
| WO-2002083759-A2 | SILICONE LIQUID CRYSTALS, VESICLES, AND GELS | DOW CORNING CORPORATION (US) | 2002-10-24 | — | — | WO | disclosed |
| US-20020082274-A1 | Preparation of sodium-hydrogen exchanger type-1 inhibitors | LAMBERT JOHN F (US) | 2002-06-27 | — | — | US | disclosed |
| US-6410583-B1 | PROSTAGLANDIN ANTAGONIST | MERCK FROSST CANADA & CO. (CA) | 2002-06-25 | — | — | US | disclosed |
| WO-2002044133-A1 | PREPARATION OF SODIUM-HYDROGEN EXCHANGER TYPE-1 INHIBITORS | PFIZER PRODUCTS INC. (US) | 2002-06-06 | — | — | WO | disclosed |
| US-6380196-B1 | BRONCHIAL THERAPEUTICS, BRONCHIAL DILATORS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2002-04-30 | — | — | US | disclosed |
| CN-1345239-A | Heterocyclic containing biphenyl alpha P2 inhibitors and method | BRISTOL MYERS SQUIBB CO (US) | 2002-04-17 | — | — | CN | disclosed |
| WO-2002008186-A2 | CYCLOPENTANOINDOLES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF TREATMENT | MERCK FROSST CANADA & CO. (CA) | 2002-01-31 | — | — | WO | disclosed |
| EP-1042319-A1 | DIHYDROBENZOFURANS | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| US-6103718-A | Phthalazinones | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 2000-08-15 | — | — | US | disclosed |
| EP-0971901-A1 | PHTHALAZINONES | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 2000-01-19 | — | — | EP | disclosed |
| WO-1999031090-A1 | DIHYDROBENZOFURANS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1999-06-24 | — | — | WO | disclosed |
| WO-1998031674-A1 | PHTHALAZINONES | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1998-07-23 | — | — | WO | disclosed |
| CN-1148340-A | Treatment of 5HTZBMethods of receptor-related disorders | LILLY CO ELI (US) | 1997-04-23 | — | — | CN | disclosed |
| EP-0485636-B1 | INDOLE DERIVATIVE | TORAY INDUSTRIES (JP) | 1997-03-12 | — | — | EP | disclosed |
| EP-0735026-A1 | Method for the production of isoquinoline derivatives and their use as intermediates in the preparation of indole derivatives | TORAY INDUSTRIES, INC. (JP) | 1996-10-02 | — | — | EP | disclosed |
| US-5539119-A | MULTISTAGE FORMATION BY OXIDATION, REDUCING A CARBAMATE TO FORM AN ENAMINE, FORMING AN OXIDE | TORAY INDUSTRIES, INC. (JP) | 1996-07-23 | — | — | US | disclosed |
| US-5244904-A | Immunorepressant, analgesic | TORAY INDUSTRIES, INC. (JP) | 1993-09-14 | — | — | US | disclosed |
| EP-0485636-A1 | INDOLE DERIVATIVE | TORAY INDUSTRIES, INC. (JP) | 1992-05-20 | — | — | EP | disclosed |
| EP-0101934-B1 | PROCESS FOR THE PREPARATION OF 1-(HALOALKYL)-1,2,3,4-TETRAHYDRO-BETA-CARBOLINES | BASF Aktiengesellschaft (DE) | 1988-03-23 | — | — | EP | disclosed |
| US-4565870-A | Process for the preparation of a salt of 1-(γ-halopropyl)-1,2,3,4-β-carbolines | BASF AKTIENGESELLSCHAFT (DE) | 1986-01-21 | — | — | US | disclosed |
| US-4539579-A | ELECTROCHROMIC RECORDING | THE HILTON-DAVIS CHEMICAL CO. (US) | 1985-09-03 | — | — | US | disclosed |
| EP-0141962-A1 | Hydrazine derivatives of fluorans and use thereof in electrochromic recording systems | THE HILTON - DAVIS CHEMICAL COMPANY (US) | 1985-05-22 | — | — | EP | disclosed |
| EP-0108382-A1 | Hydrazine derivatives of phthalides and furopyridinones, methods for making and for using said compounds | STERLING DRUG INC. (US) | 1984-05-16 | — | — | EP | disclosed |
| EP-0101934-A1 | Process for the preparation of 1-(haloalkyl)-1,2,3,4-tetrahydro-beta-carbolines | BASF Aktiengesellschaft (DE) | 1984-03-07 | — | — | EP | disclosed |
| US-4351948-A | Imidazole hydrazone derivatives | G.D. SEARLE & CO. (US) | 1982-09-28 | — | — | US | disclosed |
| US-4094906-A | INSECTICIDES AND MITICIDES | THE UPJOHN COMPANY (US) | 1978-06-13 | — | — | US | disclosed |
| US-4026885-A | Process for the manufacture of cationic hydrazone dyes | CIBA-GEIGY CORPORATION (US) | 1977-05-31 | — | — | US | disclosed |
| US-4008217-A | HERBICIDE | THE UPJOHN COMPANY (US) | 1977-02-15 | — | — | US | disclosed |
| US-3987234-A | ACRYLIC ESTER POLYMERS | HENKEL & CIE G.M.B.H. (DT) | 1976-10-19 | — | — | US | disclosed |
| US-3948939-A | 9-Acyl-1,2,3,4-tetrahydrocarbazole-3 and 4-carboxylic acids | STERLING DRUG INC. (US) | 1976-04-06 | — | — | US | disclosed |
| US-3948939-A | 9-Acyl-1,2,3,4-tetrahydrocarbazole-3 and 4-carboxylic acids | STERLING DRUG INC. (US) | 1976-04-06 | — | — | US | disclosed |